1523. Deputy David Stanton asked the Minister for Health further to Parliamentary Questions Nos. 202 to 205, inclusive, of 2 March 2022, if he will provide an update on the possible reimbursement of gene therapy treatment, voretigene neparvovec luxturna, for the treatment of sight loss; and if he will make a statement on the matter. [19931/22]

Summary

1523. Deputy David Stanton asked the Minister for Health further to Parliamentary Questions Nos. 202 to 205, inclusive, of 2 March 2022, if he will provide an update on the possible reimbursement of gene therapy treatment, voretigene neparvovec luxturna, for the treatment of sight loss; and if he will make a statement on the matter. [19931/22]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 26 April 2022

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.